BioSpace News Archive

Biodesix, Inc., a leading data-driven diagnostic solutions company with a focus in lung disease, announced Scott Hutton, Chief Executive Officer of Biodesix, will participate in two upcoming investor conferences.

NanoString Technologies, Inc., a leading provider of life science tools for discovery and translational research, announced that company management is scheduled to webcast presentations from two upcoming healthcare conferences.

Henry Schein, Inc. announced that the Company will present at the following investor conferences: Morgan Stanley 21st Annual Global Healthcare Conference in New York on September 11, 2023, at 10:00 a.m. Eastern time.

ADC Therapeutics SA announced that Ameet Mallik, Chief Executive Officer, will participate in two investor conferences in September.

Crossject (ISIN: FR0011716265; Euronext:ALCJ) announces that its manufacturing sites in Dijon and Gray (France) have passed an annual ISO certification audit, expanded their scope of certification by French Health Agency, and received positive feedback after an audit by the Biomedical Advanced Research and Development Authority (BARDA).

Engitix Ltd, a biotechnology company with a portfolio of drug discovery programmes in fibrosis and solid tumours using its proprietary patient-centric human extracellular matrix platform, announces the appointment of Christopher Stevenson, Ph.D., as Chief Scientific Officer.

First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First Wave BioPharma” or the “Company”) today announced that James Sapirstein, Chairman and Chief Executive Officer, will deliver a virtual presentation at the H.C. Wainwright 25th Annual Global Investment Conference being held September 11-13, 2023.

TScan Therapeutics, Inc., a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment of patients with cancer, announced that management will participate in the following upcoming investor conferences.

Galera Therapeutics, Inc. announced that Mel Sorensen, M.D., President and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023, at 4:30 p.m. E.T.

Cara Therapeutics, Inc. announced that Christopher Posner, President and Chief Executive Officer, will present at the H.C. Wainwright 25th Annual Global Investment Conference on Monday, September 11, 2023, at 9:00 a.m. EDT in New York, NY.